All In MedTech

Device Trial Radar · NCT06117501

Nerve Protection Evaluation: Revision Cubital Tunnel Syndrome Decompression

Last checked: Nov 19, 2026Latest source record: Oct 13, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

19

Actual

Start

Oct 19, 2023

Primary completion

Aug 17, 2026

Study completion Aug 17, 2026

Sponsor

Lead sponsor
Axogen CorporationNot on our public-company list
Sponsor type
Industry
First posted
Nov 7, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This single-cohort, prospective case series is designed to evaluate and characterize the use of Axoguard HA+ Nerve Protector™ to protect the ulnar nerve in a first revision cubital tunnel decompression procedure. Data on the primary cubital tunnel syndrome decompression, first revision decompression utilizing Axoguard HA+ Nerve Protector, participant-reported pain, motor and sensory functional outcomes, quality of life (QoL) outcomes, and recurrence/revision will be collected. This case series will help to establish the ability of Axoguard HA+ Nerve Protector to provide clinical benefits for patients undergoing a first revision cubital tunnel decompression procedure.

Conditions

  • Recurrent Cubital Tunnel Syndrome
  • Recalcitrant Cubital Tunnel Syndrome

Interventions

  • Axoguard HA+ Nerve Protector™Device

    Axoguard HA+ Nerve Protector™ is a surgical implant that provides non-constricting protection for non-transected peripheral nerve injuries where there is no gap. Axoguard HA+ Nerve Protector™ is designed to be an interface between the nerve and the surrounding tissue.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Visual analog scale (VAS)Time frame: 6-18 months

Locations

7 sites in 1 country. Site status is shown where the registry gives one.

  • Foundation for Orthopaedic Research and Education (Florida Orthopaedic Institute)

    Tampa, Florida

  • Optim Orthopedics

    Savannah, Georgia

  • Indiana Hand to Shoulder Center

    Indianapolis, Indiana

4 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.